<--- Back to Details
First PageDocument Content
Medicine / Lysosomal Acid Lipase Deficiency / Wolman disease / Cholesteryl ester storage disease / Sanfilippo syndrome / Mucopolysaccharidosis / Lysosomal storage disease / Atherosclerosis / Low-density lipoprotein / Health / Rare diseases / Lipid storage disorders
Date: 2014-06-03 10:39:51
Medicine
Lysosomal Acid Lipase Deficiency
Wolman disease
Cholesteryl ester storage disease
Sanfilippo syndrome
Mucopolysaccharidosis
Lysosomal storage disease
Atherosclerosis
Low-density lipoprotein
Health
Rare diseases
Lipid storage disorders

SYNAGEVA BIOPHARMA™ HIGHLIGHTS DATA PRESENTATIONS AND SATELLITE SYMPOSIUM AT THE EUROPEAN ATHEROSCLEROSIS SOCIETY CONGRESS LEXINGTON, Mass., June 3, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharm

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

Download Document from Web Archive

File Size: 300,40 KB